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Abstract
Background: Symptomatic gallstone disease is one of the most common problem attended by a general surgeon.
The application of minimally invasive surgical techniques for the removal of gallbladder is now an accepted and
preferred method for treating this condition. The avoidance of a subcostal incision and minimal bowel handling
leads to decreased postoperative pain, early returning to function and overall shorter duration of hospital stay.
Nevertheless, patients do have significant postoperative pain, and newer techniques to further reduce this pain are
the subject of many ongoing studies. Many intraoperative techniques for reducing postoperative pain have been
described. The current practice at many institutions, including ours, is to discharge the patient on the first
postoperative day on oral analgesics. Better control of postoperative pain may help establishing laparoscopic
cholecystectomy as a day care procedure in selected patients. The aim of this study is to determine the effect of
0.5 % bupivacaine soaked oxidized regenerated cellulose surgical versus normal saline soaked surgical applied at
the gallbladder bed on postoperative mean pain score after laparoscopic cholecystectomy for symptomatic
gallstones.
Patients and methods: Patients scheduled for laparoscopic cholecystectomy were enrolled in the study after
meeting the inclusion criteria. Relevant history was taken and clinical examination was done. Necessary
investigations were carried out. All patients were divided to receive either 0.5 % bupivacaine soaked surgicel or
normal saline soaked surgicel after laparoscopic cholecystectomy with each group having equal number of
patients. The pain score was measured with a visual analogue scale (VAS) at 4, 12 and 24 h after the procedure in
both groups. All data was recorded on performa and SPSS-19 was used for analysis.
Results: The demographic characteristic of the two groups has shown that studied patients were matched as
regarding gender, age, weight, ASA status and duration of surgery. Post-operative abdominal pain was significantly
lower in bupivacaine Group than Saline group. This difference was reported from 4 h till 12 h post-operatively.
Bradycardia, Hypotension and Urinary retention were the most common perioperative symptoms reported, with an
incidence of 28.3 % in the saline Group and 15 % in the bupivacaine group with no significant differences.
Evaluation of postoperative details such as oral intake, time to walk and length of hospital stay revealed that
bupivacaine group reported better outcomes as compared to saline group.
Conclusion: Placing bupivacaine soaked surgicel has been shown to decrease the mean postoperative pain score
in patients. No significant complication was noticed with the use of surgicel. Because adequate pain control
requires intravenous medications, additional methods for pain control need to be studied before laparoscopic
cholecystectomy can be routinely performed as a day care case.
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Introduction
Although laparoscopic cholecystectomy has numerous ben-
efits over the open method, still postoperative pain remains
an issue. Postoperative pain, requiring injectable analgesics
prolong the patient’s hospital stay, and is one of the hurdles
in performing laparoscopic cholecystectomy as a day case.
The pain reaches a maximum level within 6 h of the pro-
cedure and then gradually decreases over a couple of days,
but varies considerably between patients [1, 2]. Studies
show that postoperative analgesics may be required in 58 %
to as much as in more than 70 % of patients [3–5].
Many methods have been tried to decrease the postop-
erative pain, like low-pressure pneumoperitoneum, gasless
technique, local anesthetic infiltration, saline washout and
instillation of a local anesthetic agent in the subdiaphrag-
matic area [6–8].
The pain that a patient feels after laparoscopic chole-
cystectomy can be divided into 3 types: Visceral, parietal
and shoulder pain which have different intensities [9].
The visceral pain is because of the surgical dissection
and tissue handling at the gall bladder bed. The parietal
or somatic pain is caused by the trauma to the abdom-
inal wall from the insertion of the trocars.
According to some studies, visceral pain accounts for
most of the pain in the early postoperative period. Others
state that the largest component in the total abdominal
pain is from the incision sites, followed by the pneumo-
peritoneum and then the cholecystectomy [10]. This is in
contrast to studies that show that infiltration of a local
anesthetic agent at the trocar insertion sites does not pro-
vide pain relief, suggesting that the parietal pain does not
contribute substantially to the total pain [11, 12]. In our
study we evaluated the effect on the total pain score of the
patient at different times, not the type or difference in in-
tensities of the different types of pain. In our study, to
minimize discrepancies, bupivacaine was injected at the
trocar insertion sites as a routine procedure in both the
control and case cohorts.
The cause of the shoulder pain has not been determi-
ned—proposed causes include neuropraxia of the phrenic
nerve, stretching of the subdiaphragmatic fibers because of
the pneumoperitoneum, increased stretch on the diaphrag-
matic attachments of the liver due to loss of visceral surface
tension and peritoneal damage from chemical, ischemic or
traumatic injury [13, 14]. Shoulder tip pain has been re-
ported frequently ranging from 35 % to 63 %, but the inten-
sity is markedly lower after laparoscopic cholecystectomy
as compared to gynecologic procedures [15]. While visceral
and parietal pain reduce after 24–48 h, shoulder pain may
become more significant [16].
There is a dearth of local studies on the above subject.
This study aims to provide impetus for further research
and help in performance of laparoscopic cholecystectomy
as a day care procedure.
Patient and methods
This prospective observational control study was
approved by the Liaquat national hospital and medical
college ethical review board (Approval no #07895).
Required sample size of 120 patients was calculated with
95 % confidence level and 90 % power. These patients
were included consecutively in the study from June 2014
to December 2014 were recruited from the outpatient
clinic after obtaining written and informed consent.
Inclusion criteria was only those patients who were
undergoing laparoscopic cholecystectomy and also clas-
sified as American society of anesthesiology(ASA) I and
II. Patients having acute cholecystits, laparoscopic con-
verted to open surgery, surgery requiring placement of
drains and patients with contraindication to Intravenous
ketorolac use were excluded from this study.
All participants undergoing elective laparoscopic chole-
cystectomy were divided into two groups with concealment
of the sequence and each group having equal number of
patients. In the control group, 20 cc of normal saline
solution without bupivacaine was irrigated at the surgical
bed after laparoscopic cholecystectomy. The experimental
group was irrigated with 20 cc of bupivacaine 0.5 % in nor-
mal saline solution. Participants were kept unaware of the
treatment they received following the protocol of single
blinded study.
Following the anaesthetic assessment, patients were
admitted to the hospital the day before the operation.
All patients received the same anaesthetic technique.
Usual monitoring was used including heart rate, respira-
tory rate, continuous ECG, SpO2 and non-invasive arter-
ial blood pressure. Creation of CO2 pneumoperitoneum
at 14 mm Hg pressure was justified in all patients and
standard laparoscopic cholecystectomy using the 4-port
technique was performed. All the operations were per-
formed by one team of surgeons that is experienced in
laparoscopic surgery.
Prior hypothesis
Application of 0.5 % bupivacaine soaked surgicel at the
gall bladder bed after laparoscopic cholecystectomy will
result in a lower postoperative mean pain score com-
pared to normal saline soaked surgicel.
Data collection
A performa was filled by the researcher for each patient,
meeting inclusion criteria, in the ward, after taking writ-
ten and informed consent and explaining him or her, the
purpose of this study. The surgery was performed by a
consultant having 5 years’ experience in laparoscopic
cholecystectomy. Patients were allocated into two groups
equally by balloting by the researcher, i.e. saline group
and bupivacaine group. Participants were kept unaware
of the treatment they received following the protocol of
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single blinded study. Both groups received 2 mg/kg of
0.5 % bupivacaine infiltrated at the port sites after the
procedure to minimize the local pain. The members of
bupivacaine group also had a 3 x 3 inch strip of surgicel
soaked in 0.5 % bupivacaine placed at the gall bladder
bed, and members of saline group had a surgicel soaked
in normal saline placed at the gall bladder bed. Both
groups received similar postoperative analgesia, I/V
Ketorolac 30 mg at 8 h intervals during the study period.
The assigned researcher used the VAS to measure pain
scores at 4, 12 and 24 h after the procedure. All data, in-
cluding age, sex, comorbid, duration of symptoms, dur-
ation of procedure, and VAS score at 4, 12 and 24 h
after procedure, and the total pain score was recorded
on a performa. The study was completed at the end of
24 h with no dropouts.
Statistical analysis
Data was analyzed by using SPSS version-19. Descriptive
statistics, frequency and percentage were computed for
qualitative variables like gender and pain control. Mean
± SD was computed for presentation of age and hospital
stay. Chi square test was used to compare proportion
difference between groups for gender and the independ-
ent sample t test of the significance was used to compare
mean pain score between groups for continuous vari-
ables like age and pain score. P value ≤0.05 was taken as
significant. Confounding variables like age, gender were
controlled by stratification to see the effect on outcome
(mean pain score).
Results
A total of 120 patients undergoing laparoscopic chole-
cystectomy were included in this study. Patients were
equally allocated into two groups according to treatment
plan. The demographic characteristic of the two groups
has shown that studied patients were matched as regard-
ing gender, age, weight, ASA status and duration of sur-
gery. However, most of studied patients were females
(71.66 % and 80.3 % in saline and bupivacaine group re-
spectively). Furthermore, mean operating time of surgery
was not significantly different among the two groups
(45.8, and 46.0 min in saline and bupivacaine group re-
spectively). In addition, no significant differences were
observed among two groups with respect to age, ASA
status and weight (Table 1).
Post-operative abdominal pain was significantly lower in
bupivacaine Group than Saline group. This difference was
reported from 4 h till 12 h post-operatively. Although
bupivacaine Group also reported lower pain scores after
24 h when compared with the saline group, however it is
not statistically significant as reported (Table 2). Additional
I/V analgesia was only required in one patient.
Bradycardia, Hypotension and Urinary retention were the
most common perioperative symptoms reported, with an
incidence of 28.3 % in the saline Group and 15 % in the
bupivacaine group. There was no significant statistical dif-
ference. Three patients experienced shoulder tip pain, two
from saline group and one from bupivacaine group with
no significant difference. Six patients reported Prutitis and
Ponv, four from saline group and two from bupivacaine
group. Two patients reported headache and respiratory
problems both of them were from saline group (Table 3).
Evaluation of postoperative details such as oral intake,
time to walk and length of hospital stay revealed that
bupivacaine group reported better outcomes as com-
pared to saline group (Table 4).
Discussion
Instillation of a local anesthetic agent in the subdiaph-
ragmatic region as a method for pain control has been
evaluated in many trials [17, 18]. While some series re-
ported a benefit in terms of reduce postoperative pain,
others showed no benefit [19–21]. Important factors that
may be responsible for this difference in observations in-
clude the timing of the administration of the drug (be-
fore dissection versus after the procedure), volume of
the solution used, and the method of drug instillation
[22, 23]. Some authors believe that failure of adequate
pain relief may be attributed to a short contact time of
the drug with the surgical site due to the intraperitoneal
influx [24, 25]. Using a sheet of oxidized cellulose (surgi-
cel/tabotamp) soaked in bupivacaine, at the gall bladder
bed is thought to increase the contact time of the drug,
leading to better pain relief [26]. In our study we used a
2 inch × 3 inch strip of surgicel soaked in either
Table 2 Comparison of mean pain score between groups
Saline Group Bupivacaine Group P-value
4 h 6.8(0.72) 6.2(0.89) 0.0005
12 h 4.3(0.97) 3.9(0.99) 0.022
24 h 2.6(0.80) 2.5(0.87) 0.57
Table 1 Demographic characteristics of saline and bupivacaine
group
Saline Group Bupivacaine Group P-value
Male 17(28.33 %) 12(20.0 %) 0.394
Female 43(71.66 %) 48(80.0 %)
ASA I 43(71.66 %) 17(28.33 %) 0.528
ASA II 47(78.33 %) 13(21.66 %)
Age 43.0(11.86) 39.2(10.99) 0.073
Weight 81.28(4.15) 81.15(4.54) 0.867
Duration of Surgery 45.8(2.22) 46.0(2.11) 0.615
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bupivacaine or normal saline for the case and control
groups respectively.
In our study, a total of 120 patients that fulfilled the
inclusion criteria were included, after taking informed
consent. All the patients were prescribed a standard
postoperative analgesic regimen, which included intra-
venous ketorolac, 30 mg every 8 h.
The mean pain scores as calculated from the VAS were
significantly less for bupivacaine Group, compared to sa-
line Group at 4 h (p = 0.0005) and at 12 h (0.022), while
the difference at 24 h was not significant (p = 0.57). Verma
et al. noted a mean difference in the VAS of more than 10
between the case and control group, but this difference
was not significant at 4 or 8 h after surgery [10]. This
could be due to a small sample size with a large variation
in the VAS at 4 h. Tariq et al. report a significant differ-
ence in the case group using bupivacaine plus ketorolac
intraperitoneally, compared to bupivacaine alone [26].
Khan and coworkers also report bupivacaine at the gall
bladder bed and infiltration at the port site to be an effect-
ive way to control postoperative pain [27]. Only one pa-
tient required additional analgesia in our study from the
control group. Tariq et al also report that the difference in
analgesia requirement was not significant [26].
Stratification according to gender revealed a significant
difference in mean VAS in females at 4 and 12 h in females.
Ure and coworkers have reported that females report more
pain compared to males, therefore a significant difference
in mean pain scores in females would further ascertain our
hypothesis [4]. Data stratified according to age revealed a p
value of 0.009, 0.14 and 0.67 at 4, 12 and 24 h for the less
than 40 year age group, while for more than 40 years, these
values were 0.003, 0.091, 0.174 respectively.
Conclusion
In conclusion, there are considerable differences in the
results from various studies. In our opinion, placing a
surgicel soaked with bupivacaine at the gall bladder bed
and infiltrating bupivacaine at the trocar insertion sites
is a safe method, and decreases the postoperative pain
resulting from laparoscopic cholecystectomy. We rec-
ommend that this method of analgesia be used routinely
in surgery for symptomatic gall stones. Further research
needs to be done to assess the efficacy and possible asso-
ciated morbidity of this method in cases of acute
cholecystitis.
Consent
Written informed consent was obtained from the pa-
tients for publication of this article. A copy of the writ-
ten consent is available for review by the Editor-in-Chief
of this journal. Approval obtained from Liaquat national
hospital and medical college ethical review committee.
Abbreviations
I/V: Intravenous; VAS: Visual analogue scale; ASA: American society of
anesthesiology.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
AA, SF and FS were clinical investigators of this study. AA, SF, and MME
analyzed the data and wrote the manuscript, and MME critically revised it.
All authors read and approved the final manuscript.
Acknowledgements
We acknowledge all members of general surgery department and Syed
Danish (biostatistician) Liaquat national hospital and medical college, Karachi,
Pakistan for their cooperation.
Author details
1Department of General surgery, Liaquat national hospital and medical
college, Karachi, Pakistan. 2Intern, Liaquat national hospital and medical
college, Karachi, Pakistan. 3Intern, Dhaka medical college, Karachi, Pakistan.
Received: 8 May 2015 Accepted: 3 September 2015
References
1. Bisgaard T, Klarskov B, Rosenberg J, Kehlet H. Characterisics and prediction
of early pain after laparoscopic cholecystectomy. Pain. 2001;90:261–9.
2. Jensen K, Khlet H, Lund CM. Post-operative recovery profile after
laparoscopic cholecystectomy: a prospective, observational study of a
multimodal anaesthetic regime. Acta Anaesthesiol Scand. 2007;51:464–71.
3. Ure BM, Troidl H, Spangenberger W, Dietrich E, Lefering R, Neugebauer E.
Pain after laparoscopic cholecystectomy. Intensity and localization of pain
and analysis of predictors in preoperative symptoms and intraoperative
events. Surg Endosc. 1994;8:90–6.
4. Michaloliakou C, Chung F, Sharma S. Preoperative multimodal analgesia
facilitates recovery after ambulatory laprocopic cholecystectomy. Anesth
Analg. 1996;82:44–51.
5. Barczynski M, Herman RM. A prospective randomized trial on comparison of
low-pressure and standard pressure pneumoperitoneum for laparoscopic
cholecystectomy. Surg Endosc. 2003;17:533–8.
Table 3 Perioperative characteristics of normal saline and
bupivacaine group
Saline Group Bupivacaine Group P-value
Shoulder tip pain 2(3.3 %) 1(1.7 %) 0.559
Bradycardia 6(10.0 %) 3(5.0 %) 0.491
Hypotension 610.0 %) 4(6.7 %) 0.743
Urinary retention 5(8.3 %) 2(3.3 %) 0.243
Pruritis 2(3.3 %) 1(1.7 %) 0.559
Ponv 2(3.3 %) 1(1.7 %) 0.559
Headache 1(1.7 %) 0(0 %) 0.315
Respiratory 1(1.7 %) 0(0 %) 0.315
Table 4 Postoperative outcomes in normal saline and
bupivacaine group
Saline Group Bupivacaine Group P-value
Time of oral intake (hr) 13.21(1.74) 11.78(1.93) 0.00
Time to walk (hr) 12.81(1.46) 12.20(1.83) 0.04
Length of Hospital stay 28.33(3.14) 26.31(2.07) 0.00
Ahmad et al. Patient Safety in Surgery  (2015) 9:31 Page 4 of 5
6. Bisgaard T, Klarskov B, Kristiansen VB, Callesen T, Schulze S, Kehlet H, Rosenberg J.
Multiegional local anesthetic infiltration during laparoscopic cholecystectomy in
patients receiving prophylactic multimodal analgesia: a randomized, double-blind
placebo-controlled study. Anesth Analg. 1999;89:1017–24.
7. Wills VL, Hunt DR. Pain after laparoscopic cholecystectomy. Br J Surg.
2000;87:273–84.
8. Joris J, Thiry E, Paris P, Weerts J, Lamy M. Pain after laparoscopic
cholecystectomy: characteristics and effect of intraperitoneal bupivacaine.
Anesth Analg. 1995;81(2):379–84.
9. Mouton WG, Bessel JR, Otten KT, Madden GJ. Pain after laparoscopy. Surg
Endosc. 1999;13:445–8.
10. Verma GR, Lyngdoh TS, Kaman L, Bala I. Placement of 0.5 % Bupivacaine
soaked Srgicel in the gall bladder bed is effective for pain after laparoscopic
cholecystectomy. Surg Endosc. 2006;20(10):1560–4.
11. Adams WJ, Avramovic J, Barraclough BH. Wound infiltration with 0.25 %
buivacaine is not effective for postoperative analgesia after
cholecystectomy. Aust N Z J Surg. 1991;61:626–30.
12. Timoyiannis EC, Glantzounis G, Lakkas ET, Siakas P, Jabarin M, Tzourou H.
Intraperitoneal normal saline and Bupivacaine infusion for reduction of
postoperative pain after laparoscopic cholecystectomy. Surg Laparosc
Endosc. 1998;8(6):416–20.
13. Woolf CJ, Mannion RJ. Neuropathic pain: etiology, symptoms, mechanisms
and management. Lancet. 1999;353(9168):1959–64.
14. Dobbs FF, Kumar V, Alexander JI, Hull MG. Pain after laparoscopic
cholecystectomy related to posture and ring versus clip sterilization.
Br J Obstet Gynaecol. 1987;4(3):262–6.
15. Mravoic B, Jurisic T, Kogler-Majeric V, Sustic A. Intraperitoneal bupivacaine
for analgesia after laparoscopic cholecystectomy. Acta Anaesthesiol Scand.
1997;41:193–6.
16. Elfberg BA, Sjovall-Mjoberg S. Intraperitoneal bupivacaine does not
effectively reduce pain after laparoscopic cholecystectomy: a randomized,
placebo-controlled and double blind study. Surg Laprosc Endosc.
2000;6:357–9.
17. Cunniffe MG, McAnena OJ, Dar MA, Calleary J, Flynn N. A prospective
randomized trial of intraoperative bupivacaine irrigation for management of
shoulder tip pain following laparoscopy. Am J Surg. 1998;176:258–61.
18. Lepner U, Goroshima J, Smarutel J. Postoperative pain relief after
laparoscopic cholecystectomy: a randomized double-blind clinical trial. Scan
J Surg. 2003;92:121–4.
19. Sarac AM, Aktan AO, Baykan N, Yagen C, Yalin R. The effect and timing of
local anesthesia in laparoscopic cholecystectomy. Surg Lap Endosc.
1996;6:362–6.
20. Rademaker BM, Kalkman CJ, Odoom JA, Wit LD, Ringers J. Intraperitoneal
local anesthetics after laparoscopic cholecystectomy: effect on
postoperative pain, metabolic responses and lung function. Br J Anesth.
1994;72:263–6.
21. Pascqualucci A, De Angelis V, Contardo R, Colo F, Terrosu G, Donini A,
Pasetto A, Bresadola F. Preemptive analgesia: A randomized, double-blind,
placebo-controlled study. Anesthesiology. 1996;85:11–20.
22. Maestroni U, Sarli D, Devito C. Pour Morard Kohan Brunaldi F, Anania G,
Pavanelli L, Pasqualucci A, Donini A. A new method of preemptive
analgesia in laparoscopic cholecystectomy. Surg Endosc. 2002;16:1336–40.
23. Schulte-Steinberg H, Weninger E, Jokisch D, Hofstetter B, Misera A, Lange V.
Intraperitoneal versus interpleural morphine or bupivacaine for pain after
laparoscopic cholecystectomy. Anesthsiology. 1995;82:634–40.
24. Scheinin B, Kellokumpu I, Lindgren L, Haglund C, Rosenberg PH. Effect of
Intraperitoneal bupivacaine on pain after laparoscopic cholecystectomy.
Acta Anesthesiol Scand. 1995;39:195–8.
25. Feroci F, Kroning KC, Scatizzi M. Effectiveness for pain after laparoscopic
cholecystectomy of 0.5 % Bupivacaine-soaked Tabotamp placed in the gall
bladder bed: a prospective, randomized clinical trial. Surg Endosc.
2009;23(10):2214–20.
26. Tariq GR, Mian MA, Chaudry IA. Comparison of intraperitoneal analgesia
with Bupivacaine/Bupivacaine with Ketorolac after laparoscopic
cholecystectomy. J Surg Pak. 2004;9(3):9–13.
27. Khan SA, Butt K, Chaudry ZA, Mushtaq A. Experience with 0.5 % Bupivacaine
pro-peritoneal bleb after laparoscopic cholecystectomy- a new trend in
analgesia. Ann King Edward Med Coll. 2000;6–4:359–60.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ahmad et al. Patient Safety in Surgery  (2015) 9:31 Page 5 of 5
